Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | HMGCR | P04035 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | ACACB | O00763 | 1/20 | 0.31 |
| ▸ | ACACA | Q13085 | 1/20 | 0.31 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.30 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1171110 | 1.00 | TSHR (0.38) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL1304385 | 1.00 | TSHR (0.38) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL3005971 | 0.89 | TSHR (0.38) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL1171879 | 0.87 | ALDH1A1 (0.33) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL28393272 | 0.86 | ALDH1A1 (0.43) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL1170981 | 0.84 | ALDH1A1 (0.32) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL3095021 | 0.83 | TSHR (0.38) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| SCHEMBL11325260 | 0.82 | ALDH1A1 (0.33) | TSHRALDH1A1HIF1A | |
| Alcohol SCHEMBL29120271 | 0.82 | ALDH1A1 (0.42) | TSHRALDH1A1CYP2D6CYP2C19HIF1A | |
| Ethylene Glycol SCHEMBL1171759 | 0.82 | TSHR (0.42) | TSHRALDH1A1CYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637544-B2 | UV curable silicone composition and cured product thereof | DUROPTIX MATERIALS KABUSHIKI KAISHA (JP) | 2026-05-26 | — | — | US | disclosed |
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | FUJIFILM CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| EP-4703778-A1 | WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE | Dai Nippon Printing Co., Ltd. (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | FUJIFILM CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4202505-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACKLIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE IN WHICH SAME IS USED, AS WELL AS METHOD FOR SELECTING BARRIER FILM | DAINIPPON PRINTING CO LTD (JP) | 2026-02-18 | — | — | EP | disclosed |
| EP-4201667-B1 | BARRIER FILM, AND WAVELENGTH CONVERSION SHEET, BACK LIGHT, AND LIQUID CRYSTAL DISPLAY DEVICE WHICH USE SAME | DAINIPPON PRINTING CO LTD (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-12496802-B2 | Barrier film, wavelength conversion sheet using same, backlight and liquid crystal display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2025-12-16 | — | — | US | disclosed |
| US-12492293-B2 | Multi-component systems for preparing foamed products | ARKEMA FRANCE (FR) | 2025-12-09 | — | — | US | disclosed |
| EP-4202506-B1 | BARRIER FILM, WAVELENGTH CONVERSION SHEET USING SAME, BACKLIGHT AND LIQUID CRYSTAL DISPLAY DEVICE | DAINIPPON PRINTING CO LTD (JP) | 2025-11-26 | — | — | EP | disclosed |
| EP-4579289-A1 | WAVELENGTH CONVERSION SHEET, AND BACKLIGHT AND LIQUID CRYSTAL DISPLAY DEVICE USING SAME | Dai Nippon Printing Co., Ltd. (JP) | 2025-07-02 | — | — | EP | disclosed |
| EP-1983017-A1 | CURABLE COMPOSITION CONTAINING THIOL COMPOUND | Showa Denko K.K. (JP) | 2008-10-22 | — | — | EP | disclosed |
| EP-1629046-B1 | CURABLE POLYMER COMPOUND | SHOWA DENKO KK (JP) | 2008-05-14 | — | — | EP | disclosed |
| US-7341828-B2 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2008-03-11 | — | — | US | disclosed |
| US-20070083012-A1 | Curable polymer compound | SHOWA DENKO K.K. (JP) | 2007-04-12 | — | — | US | disclosed |
| US-20070021571-A1 | Curable polymer compound | SHOWA DENKO K.K. (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060079593-A1 | Hexaarylbiimidazole compounds and photopolymerization initiator compositions containing the same | SHOWA DENKO K.K. (JP) | 2006-04-13 | — | — | US | disclosed |
| US-20060041053-A1 | Color filter black matrix resist composition and carbon black dispersion composition used for the composition | SHOWA DENKO K.K. (JP) | 2006-02-23 | — | — | US | disclosed |
| US-20060036023-A1 | Color filter black matrix resist composition | SHOWA DENKO K.K. (JP) | 2006-02-16 | — | — | US | disclosed |
| US-20050258406-A1 | Black resist composition for color filter | SHOWA DENKO K.K. | 2005-11-24 | — | — | US | disclosed |
| US-20050153231-A1 | Thiol compound, photopolymerization initiator composition and photosensitive composition | SHOWA DENKO K.K. (JP) | 2005-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637544-B2 | UV curable silicone composition and cured product thereof | QSOX1, MGMT, TST | TSHR 3875/4885ALDH1A1 70/4885CYP2D6 1172/4885 |
| US-12624279-B2 | Quantum dot-containing polymerizable composition, cured product, wavelength conversion member, backlight unit, and liquid crystal display device | NLRP1, NLRP3, ALAD | TSHR 2197/4885ALDH1A1 45/4885CYP2D6 2719/4885 |
| US-12565548-B2 | Compound, polymerizable composition, and cured product | SEM1, PSMA1, RER1 | TSHR 4589/4885ALDH1A1 1138/4885CYP2D6 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.